BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24934660)

  • 1. A novel model for Ki67 assessment in breast cancer.
    Romero Q; Bendahl PO; Fernö M; Grabau D; Borgquist S
    Diagn Pathol; 2014 Jun; 9():118. PubMed ID: 24934660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
    Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
    Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlaboratory variability of Ki67 staining in breast cancer.
    Focke CM; Bürger H; van Diest PJ; Finsterbusch K; Gläser D; Korsching E; Decker T;
    Eur J Cancer; 2017 Oct; 84():219-227. PubMed ID: 28829990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
    Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
    J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
    Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
    Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer.
    Christgen M; von Ahsen S; Christgen H; Länger F; Kreipe H
    Hum Pathol; 2015 Sep; 46(9):1341-9. PubMed ID: 26206765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.
    Romero Q; Bendahl PO; Klintman M; Loman N; Ingvar C; Rydén L; Rose C; Grabau D; Borgquist S
    BMC Cancer; 2011 Aug; 11():341. PubMed ID: 21819622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.
    Chen Y; Klingen TA; Wik E; Aas H; Vigeland E; Liestøl K; Garred Ø; Mæhlen J; Akslen LA; Lømo J
    Diagn Pathol; 2014 Dec; 9():230. PubMed ID: 25522915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
    Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
    Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer.
    Cserni B; Bori R; Csörgő E; Oláh-Németh O; Pancsa T; Sejben A; Sejben I; Vörös A; Zombori T; Nyári T; Cserni G
    Virchows Arch; 2021 Dec; 479(6):1101-1109. PubMed ID: 34415429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international Ki67 reproducibility study.
    Polley MY; Leung SC; McShane LM; Gao D; Hugh JC; Mastropasqua MG; Viale G; Zabaglo LA; Penault-Llorca F; Bartlett JM; Gown AM; Symmans WF; Piper T; Mehl E; Enos RA; Hayes DF; Dowsett M; Nielsen TO;
    J Natl Cancer Inst; 2013 Dec; 105(24):1897-906. PubMed ID: 24203987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
    Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y
    Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
    Røge R; Riber-Hansen R; Nielsen S; Vyberg M
    Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.
    Fasching PA; Heusinger K; Haeberle L; Niklos M; Hein A; Bayer CM; Rauh C; Schulz-Wendtland R; Bani MR; Schrauder M; Kahmann L; Lux MP; Strehl JD; Hartmann A; Dimmler A; Beckmann MW; Wachter DL
    BMC Cancer; 2011 Nov; 11():486. PubMed ID: 22081974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.
    Wang YX; Wang YY; Yang CG; Bu H; Yang WT; Wang L; Xu WM; Zhao XL; Zhao WX; Li L; Song SL; Yang JL
    Breast; 2020 Feb; 49():225-232. PubMed ID: 31911370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.
    Maeda I; Abe K; Koizumi H; Nakajima C; Tajima S; Aoki H; Tsuchiya J; Tsuchiya S; Tsuchiya K; Shimo A; Tsugawa K; Ueno T; Tatsunami S; Takagi M
    Breast Cancer; 2016 Sep; 23(5):745-51. PubMed ID: 26271611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer.
    Thomas S; Kabir M; Butcher BE; Chou S; Mahajan H; Farshid G; Balleine R; Pathmanathan N
    Breast Cancer Res Treat; 2021 Aug; 188(3):729-737. PubMed ID: 33751322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
    Robertson S; Acs B; Lippert M; Hartman J
    Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
    Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
    JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer.
    Robertson S; Stålhammar G; Darai-Ramqvist E; Rantalainen M; Tobin NP; Bergh J; Hartman J
    J Clin Pathol; 2018 Sep; 71(9):787-794. PubMed ID: 29588372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.